Publications by authors named "Wei Jiang Ye"
Objective: To evaluate tolvaptan as a novel therapeutic option for Chinese patients with liver cirrhosis-associated ascites in a phase 2 clinical trial.
Methods: This randomized, double-blind, placebo-controlled, multicenter trial was conducted in patients with insufficient responses to combination therapies of an oral loop diuretic and an aldosterone antagonist. Reduction in body weight and abdominal circumference, increase in 24-h cumulative urine volume and improvement in serum sodium level from baseline to the end of treatment in the tolvaptan groups (15 mg/day or 30 mg/day orally) were compared with those in the placebo group.
Background: The present study investigated the prevalence of refractive error, visual impairment, and eye diseases in school-aged children in western China.
Methods: The survey was done in a representative county (Yongchuan District, Chongqing Municipality) of western China. Cluster random sampling was used to select children aged 6 to 15 years.
Objective: This study investigated the distribution pattern of refractive status and prevalence of refractive errors in school-age children in Western China to determine the possible environmental factors.
Methods: A random sampling strategy in geographically defined clusters was used to identify children aged 6-15 years in Yongchuan, a socio-economically representative area in Western China. We carried out a door-to-door survey and actual eye examinations, including visual acuity measurements, stereopsis examination, anterior segment and eyeball movements, fundus examinations, and cycloplegic retinoscopy with 1% cyclopentolate.
Objective: To explore the clinical effects of combined slower plasma exchange (PE) and continuous veno-venous hemofiltration (CVVH) with a parallel circuit in the treatment of chronic severe viral hepatitis B patients.
Methods: 104 patients with chronic severe viral hepatitis B were divided into three groups: 44 patients were treated with a parallel circuit of combined slower plasma exchange and continuous veno-venous hemofiltration (group A), 30 patients were treated with plasma exchange (group B), and 30 patients received routine treatment (group C). Efficacy of treatment and survival rate in three groups were investigated.
[Combined non-biological artificial liver in treatment of late stage chronic severe hepatitis].
Zhonghua Gan Zang Bing Za Zhi
September 2006
Objective: To explore the clinical effects of combined non-biological artificial liver in the treatment of late stage chronic severe hepatitis and especially to observe their effects on hepatic encephalopathy, hepatorenal syndrome and disturbance of electrolytes.
Methods: 103 chronic severe hepatitis patients were treated with the same medical measures, including plasma exchange. Among them, 63 patients were also treated with combinations of non-biological artificial liver (treatment group), and the other 40 patients served as controls (control group).
Article Synopsis
- The study aimed to assess the effectiveness of combining plasma exchange and continuous veno-venous hemofiltration for treating patients with chronic severe viral hepatitis B, focusing on their clinical outcomes and underlying mechanisms.
- A total of 94 patients were divided into three groups for treatment: group A received the combined therapy, group B had plasma exchange alone, and group C received standard treatment, with survival rates and cytokine levels compared among the groups.
- Results indicated that the combined treatment in group A led to significant improvements in survival rates and cytokine levels, suggesting it as an effective artificial liver support system for patients with advanced liver disease.